FGF21 and Parkinson disease: Fibroblast growth factor 21 levels have been proven to ameliorate brain metabolic disorders and behavioral deficits in PD mouse models by promoting a favorable colonic microbiota composition and influencing the microbiota-gut-brain metabolic axis (Yang et al., 2023).